Vascular access devices registry as a working tool to improve infection control and thromboembolism management in cancer patients
Author Block: M. Cherkashin, S. Alexandrov, F. Valieva, A. Nikolaev, T. Bolshakova, E. Ilyukhin, N. Berezina; Saint-Petersburg/RU
Purpose: The aim of this study was to discuss permanent vascular access devices registry development and implementation.
Methods or Background: Vascular access devices (port-systems, peripherally implanted central catheters etc) characterised by thrombotic and infectious complications. After device implantation oncology patient can receive different types of anti-tumour therapy in different hospitals and sometimes it's very hard to obtain clear information - which device was implanted, were there any complications etc. The applicable way to exchange clinically important information between hospitals is creation of electronic registers with access for healthcare providers, involved in patient management. We decided to use online platform "Russian Registry of Treatment of Venous Thromboembolism" (NCT03881345) with some customisation, related to central venous devices, concominante blood stream infections, device malfunctions etc.
Results or Findings: Registry was started with 3 hospitals operating with paediatric oncology in St Petersburg. System development includes relevant steps: level of access (in each hospital should be dedicated owner with total access and each healthcare provider, involved in device management should have rights to upload information); data fields customisation (type of device, place of insertion, technical features during implantation, complications, malfunctions, thrombosis/occlusion, infection, therapy etc). In first month since process was started, 24 cases were uploaded (14 port-a-caths, 8 PICCs, 2 midlines) based on retrospective data we estimate 400-600 cases per year.
Conclusion: Registry is the extremely helpful tool for patient tracking during all stages of cancer treatment. Based on our results, such types of initiatives should be spreaded on city level with all paediatric oncology departments involvement.
Limitations: No information was provided by the submitter.
Funding for this study: This study was funded by the hospital.
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: This study was funded approved by Local ethics committee.